Fortuna CG - Search Results

1

Identification of genes involved in the sensitivity to antitumour drug 17-allylamino,17-demethoxygeldanamycin (17AAG).

Barresi V, Fortuna CG, Garozzo R, Musumarra G, Scirè S, Condorelli DF. Barresi V, et al. Among authors: fortuna cg. Mol Biosyst. 2006 May;2(5):231-9. doi: 10.1039/b518093g. Epub 2006 Feb 23. Mol Biosyst. 2006. PMID: 16880941

2

In vitro antitumor activities of 2,6-di-[2-(heteroaryl)vinyl]pyridines and pyridiniums.

Barresi V, Condorelli DF, Fortuna CG, Musumarra G, Scirè S. Barresi V, et al. Among authors: fortuna cg. Bioorg Med Chem. 2002 Sep;10(9):2899-904. doi: 10.1016/s0968-0896(02)00142-6. Bioorg Med Chem. 2002. PMID: 12110310

3

Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides.

Ballistreri FP, Barresi V, Benedetti P, Caltabiano G, Fortuna CG, Longo ML, Musumarra G. Ballistreri FP, et al. Among authors: fortuna cg. Bioorg Med Chem. 2004 Apr 1;12(7):1689-95. doi: 10.1016/j.bmc.2004.01.018. Bioorg Med Chem. 2004. PMID: 15028261

4

Structure-based rationalization of antitumor drugs mechanism of action by a MIF approach.

Cruciani G, Benedetti P, Caltabiano G, Condorelli DF, Fortuna CG, Musumarra G. Cruciani G, et al. Among authors: fortuna cg. Eur J Med Chem. 2004 Mar;39(3):281-9. doi: 10.1016/j.ejmech.2003.11.013. Eur J Med Chem. 2004. PMID: 15051177

5

Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA.

Musumarra G, Barresi V, Condorelli DF, Fortuna CG, Scirè S. Musumarra G, et al. Among authors: fortuna cg. Comput Biol Chem. 2005 Jun;29(3):183-95. doi: 10.1016/j.compbiolchem.2005.04.005. Comput Biol Chem. 2005. PMID: 15979038

6

Design, synthesis, and biological evaluation of 4-alkyliden-beta lactams: new products with promising antibiotic activity against resistant bacteria.

Broccolo F, Cainelli G, Caltabiano G, Cocuzza CE, Fortuna CG, Galletti P, Giacomini D, Musumarra G, Musumeci R, Quintavalla A. Broccolo F, et al. Among authors: fortuna cg. J Med Chem. 2006 May 4;49(9):2804-11. doi: 10.1021/jm0580510. J Med Chem. 2006. PMID: 16640341

7

Design and synthesis of trans 2-(furan-2-yl)vinyl heteroaromatic iodides with antitumour activity.

Fortuna CG, Barresi V, Berellini G, Musumarra G. Fortuna CG, et al. Bioorg Med Chem. 2008 Apr 1;16(7):4150-9. doi: 10.1016/j.bmc.2007.12.042. Epub 2007 Dec 25. Bioorg Med Chem. 2008. PMID: 18248996

8

Design, synthesis and biological evaluation of trans 2-(thiophen-2-yl)vinyl heteroaromatic iodides.

Fortuna CG, Barresi V, Musumarra G. Fortuna CG, et al. Bioorg Med Chem. 2010 Jun 15;18(12):4516-23. doi: 10.1016/j.bmc.2010.04.060. Epub 2010 May 18. Bioorg Med Chem. 2010. PMID: 20488719

9

OPLS-DA as a suitable method for selecting a set of gene transcripts discriminating RAS- and PTPN11-mutated cells in acute lymphoblastic leukaemia.

Musumarra G, Condorelli DF, Fortuna CG. Musumarra G, et al. Among authors: fortuna cg. Comb Chem High Throughput Screen. 2011 Jan;14(1):36-46. doi: 10.2174/1386207311107010036. Comb Chem High Throughput Screen. 2011. PMID: 20958258

10

Synthesis and NLO properties of new trans 2-(thiophen-2-yl)vinyl heteroaromatic iodides.

Fortuna CG, Bonaccorso C, Qamar F, Anu A, Ledoux I, Musumarra G. Fortuna CG, et al. Org Biomol Chem. 2011 Mar 7;9(5):1608-13. doi: 10.1039/c0ob00046a. Epub 2011 Jan 18. Org Biomol Chem. 2011. PMID: 21243151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters